These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9336468)

  • 41. Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers.
    Mir AA; Lockett TJ; Hendry P
    Nucleic Acids Res; 2001 May; 29(9):1906-14. PubMed ID: 11328874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of a novel high affinity metal-binding site in the hammerhead ribozyme.
    Hansen MR; Simorre JP; Hanson P; Mokler V; Bellon L; Beigelman L; Pardi A
    RNA; 1999 Aug; 5(8):1099-104. PubMed ID: 10445883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient ligation of the Schistosoma hammerhead ribozyme.
    Canny MD; Jucker FM; Pardi A
    Biochemistry; 2007 Mar; 46(12):3826-34. PubMed ID: 17319693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA.
    Fell PL; Hudson AJ; Reynolds MA; Usman N; Akhtar S
    Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):319-26. PubMed ID: 9303183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-function relationships of hammerhead ribozymes: from understanding to applications.
    Sigurdsson ST; Eckstein F
    Trends Biotechnol; 1995 Aug; 13(8):286-9. PubMed ID: 7662303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 4-thio-U cross-linking identifies the active site of the VS ribozyme.
    Hiley SL; Sood VD; Fan J; Collins RA
    EMBO J; 2002 Sep; 21(17):4691-8. PubMed ID: 12198171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-magnesium, trans-cleavage activity by type III, tertiary stabilized hammerhead ribozymes with stem 1 discontinuities.
    Burke DH; Greathouse ST
    BMC Biochem; 2005 Aug; 6():14. PubMed ID: 16095542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fast cleavage kinetics of a natural hammerhead ribozyme.
    Canny MD; Jucker FM; Kellogg E; Khvorova A; Jayasena SD; Pardi A
    J Am Chem Soc; 2004 Sep; 126(35):10848-9. PubMed ID: 15339162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probing general base catalysis in the hammerhead ribozyme.
    Thomas JM; Perrin DM
    J Am Chem Soc; 2008 Nov; 130(46):15467-75. PubMed ID: 18950173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An extra nucleotide in the consensus catalytic core of a viroid hammerhead ribozyme: implications for the design of more efficient ribozymes.
    De la Peña M; Flores R
    J Biol Chem; 2001 Sep; 276(37):34586-93. PubMed ID: 11454858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hammerhead ribozyme structure probed by cell extracts.
    Wang JY; Qiu L; Drlica K
    Gene; 1996 Nov; 181(1-2):117-20. PubMed ID: 8973318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A conformational change in the catalytic core of the hammerhead ribozyme upon cleavage of an RNA substrate.
    Simorre JP; Legault P; Hangar AB; Michiels P; Pardi A
    Biochemistry; 1997 Jan; 36(3):518-25. PubMed ID: 9012667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro evolution suggests multiple origins for the hammerhead ribozyme.
    Salehi-Ashtiani K; Szostak JW
    Nature; 2001 Nov; 414(6859):82-4. PubMed ID: 11689947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inter-domain cross-linking and molecular modelling of the hairpin ribozyme.
    Earnshaw DJ; Masquida B; Müller S; Sigurdsson ST; Eckstein F; Westhof E; Gait MJ
    J Mol Biol; 1997 Nov; 274(2):197-212. PubMed ID: 9398527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tolerance to exchanges of the Watson Crick base pair in the hammerhead ribozyme core is determined by surrounding elements.
    Przybilski R; Hammann C
    RNA; 2007 Oct; 13(10):1625-30. PubMed ID: 17666711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
    Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure of an anti-HIV-1 hammerhead ribozyme complex with a 17-mer DNA substrate analog of HIV-1 gag RNA and a mechanism for the cleavage reaction: 750 MHz NMR and computer experiments.
    Ojha RP; Dhingra MM; Sarma MH; Myer YP; Setlik RF; Shibata M; Kazim AL; Ornstein RL; Rein R; Turner CJ; Sarma RH
    J Biomol Struct Dyn; 1997 Oct; 15(2):185-215. PubMed ID: 9399149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.